Zacks Small Cap Research on MSN18 小时
NRXBF: Promising Company Releases Results
NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries and these numbers suggest a ...
A young woman has miraculously learned how to walk again - after a horror showjumping accident left her paralysed from the ...
Children with severe SMA have substantial loss of motor and sensory neurons in the thoracic region of the spinal cord, a ...
A new report from the University of British Columbia suggests there is an “alarming” number of people getting spinal cord ...
We are pleased to introduce the collection Frontiers in Musculoskeletal Disorders – Highlights in Spine Conditions. This ...
Two-year-old Lydia is battling Sanfilippo Syndrome type B, an incurable genetic disease that mainly affects the brain and ...
When a vertebrate embryo develops, a group of cells self-organizes into the neural tube, eventually becoming the brain and ...
Nagpur: Restoring sexual activity, along with many other body functions such as mobility, skin sensation, and blood pressure among spinal cord injury victims, could be a reality soon. Scientists ...
Kessler Foundation researchers published new findings on neuromodulation in individuals with high-level spinal cord injury (SCI) using spinal cord transcutaneous stimulation (scTS). This promising ...
After a spinal cord injury, nearby cells quickly rush to action, forming protective scar tissue around the damaged area to stabilize and protect it. But over time, too much scarring can prevent ...